Daiichi-Sankyo Korea chief to head KPMA’s special committee

The special committee for Japanese drug firms in Korea, under the umbrella of the Korea Pharmaceutical Manufacturers Association (KPMA), said Tuesday that it appointed Kim Dae-joong, chief executive of Daiichi-Sankyo Korea, as its new chair.

With its eight member companies, the committee will hold a kick-off meeting on June 18 to realize its vision by promoting the appropriate measures amid ...